Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Minerva Neurosciences Inc.
Minerva Neurosciences Inc business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Minerva Neurosciences Inc are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Minerva Neurosciences Inc , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Minerva Neurosciences Inc including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Minerva Neurosciences Inc and all latest updates of the company are provided.
The 2025 version of Minerva Neurosciences Inc report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Minerva Neurosciences Inc- Key Facts
2.2 Minerva Neurosciences Inc- Geographic Locations
2.3 Minerva Neurosciences Inc- Subsidiaries and Affiliates
2.4 Minerva Neurosciences Inc- Business Divisions
2.5 Minerva Neurosciences Inc- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Minerva Neurosciences Inc Strategic Analysis Review
3.1 Minerva Neurosciences Inc- Key Strategies
3.2 Minerva Neurosciences Inc- Company Outlook Statement
3.3 Minerva Neurosciences Inc- SWOT Analysis
3.3.1 Minerva Neurosciences Inc- Key Strengths
3.3.2 Minerva Neurosciences Inc- Key Weaknesses
3.3.3 Minerva Neurosciences Inc- Potential Opportunities
3.3.4 Minerva Neurosciences Inc- Potential Threats
3.4 Minerva Neurosciences Inc- Key Competitors
4. Business Description of the Company
4.1 Minerva Neurosciences Inc- Business Overview
4.2 Minerva Neurosciences Inc- Operations by Segment
5 Products and Services Details
5.1 Minerva Neurosciences Inc- Key Products
5.2 Minerva Neurosciences Inc- Key Service Areas
5.3 Minerva Neurosciences Inc- Key Brands
6 Company Developments
6.1 Minerva Neurosciences Inc- Company History
6.2 Minerva Neurosciences Inc- Latest Developments
7 Financial Analysis
7.1 Minerva Neurosciences Inc- Income Statements
7.2 Minerva Neurosciences Inc- Balance Sheet
7.3 Minerva Neurosciences Inc- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Minerva Neurosciences Inc- Direct Competitors
8.2 Minerva Neurosciences Inc- Competitor Financial Ratios comparison
8.3 Minerva Neurosciences Inc- Competitor Stock Charts Comparison
8.4 Minerva Neurosciences Inc- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!